Extent of ILM Removal and Its Impact on Outcomes of MH Surgery
Primary Purpose
Macular Holes
Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
small-extent peeling
large-extent peeling
Sponsored by
About this trial
This is an interventional treatment trial for Macular Holes focused on measuring Internal Limiting Membrane, Metamorphopsia
Eligibility Criteria
Inclusion Criteria:
- idiopathic macular hole
Exclusion Criteria:
- macular hole associated with other causative diseases
Sites / Locations
- Samsung Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Small Extent Group (SG)
Large Extent Group (LG)
Arm Description
Patients who were scheduled for surgery for idiopathic macular hole were randomly assigned to the SG. The small-extent peeling was performed in SG.
Patients who were scheduled for surgery for idiopathic macular hole were randomly assigned to the LG. The large-extent peeling was performed in LG.
Outcomes
Primary Outcome Measures
Degree of foveal elongation
Secondary Outcome Measures
metamorphopsia
Full Information
NCT ID
NCT02010138
First Posted
December 9, 2013
Last Updated
January 5, 2016
Sponsor
Samsung Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT02010138
Brief Title
Extent of ILM Removal and Its Impact on Outcomes of MH Surgery
Official Title
Extent of Internal Limiting Membrane Removal and Its Impact on Outcomes of Macular Hole Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
January 2016
Overall Recruitment Status
Completed
Study Start Date
July 2013 (undefined)
Primary Completion Date
October 2015 (Actual)
Study Completion Date
November 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Samsung Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Eligible patients who were scheduled for surgery for idiopathic macular hole (MH) were equally randomized to small extent group or large extent group depending on the extent of internal limiting membrane (ILM) to be removed. The ILM was peeled in round shape with the radius of either 0.75-disc diameter or 1.5-disc diameter according to the group. The primary analysis was conducted to identify the difference of functional and anatomical outcomes between the two groups. Subsequent analysis was performed to reveal the relationship between the functional and anatomical outcomes.
Detailed Description
This randomized clinical trial was performed at a single center. Patients who were scheduled for surgery for idiopathic macular hole (MH) were enrolled. Eligible patients were equally randomized to small extent group or large extent group depending on the extent of ILM to be removed. Random numbers were generated through computerized block-randomization.
A standard 3-port pars plana vitrectomy was performed by a single surgeon using 23-gauge vitrectomy system, with a 1-step scleral tunnel incision. After posterior vitreous detachment was achieved, peeling of the ILM was performed by an end gripping forceps with the assistance of indocyanine green dye. The ILM was peeled in round shape with the radius of either 0.75-disc diameter or 1.5-disc diameter centering at the center of the MH according to the pre-assigned group. This was followed by a complete fluid-gas exchange, and all patients were encouraged to maintain a face-down position for at least 5 days postoperatively.
Postoperative measurements of BCVA and M-score were conducted at 2- and 6-month follow-up visits by independent masked observers. The first postoperative SD-OCT scanning was usually conducted at 1 to 2 weeks after operation according to the intraocular gas status. Then, OCT scans were conducted at follow-up visits 2, and 6 months postoperatively. The same experienced examiner conducted all the OCT scans on all subjects.
Comparison of anatomical closure, BCVA, M-score, Δ BCVA, and Δ M-score were primarily performed between the two groups. Then, the parameters measured from OCT scans with changes in ETDRS visual acuity and M-score were analyzed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Macular Holes
Keywords
Internal Limiting Membrane, Metamorphopsia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
65 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Small Extent Group (SG)
Arm Type
Active Comparator
Arm Description
Patients who were scheduled for surgery for idiopathic macular hole were randomly assigned to the SG. The small-extent peeling was performed in SG.
Arm Title
Large Extent Group (LG)
Arm Type
Active Comparator
Arm Description
Patients who were scheduled for surgery for idiopathic macular hole were randomly assigned to the LG. The large-extent peeling was performed in LG.
Intervention Type
Procedure
Intervention Name(s)
small-extent peeling
Intervention Description
The internal limiting membrane was peeled in round shape with the radius of 0.75-disc diameter radius (1.5-disc diameter in total) centering at the center of the macular hole.
Intervention Type
Procedure
Intervention Name(s)
large-extent peeling
Intervention Description
The internal limiting membrane was peeled in round shape with the radius of 1.5-disc diameter radius (3.0-disc diameter in total) centering at the center of the macular hole.
Primary Outcome Measure Information:
Title
Degree of foveal elongation
Time Frame
postoperative 6months
Secondary Outcome Measure Information:
Title
metamorphopsia
Time Frame
6months
Other Pre-specified Outcome Measures:
Title
change in visual acuity
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
idiopathic macular hole
Exclusion Criteria:
macular hole associated with other causative diseases
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kunho Bae, MD
Organizational Affiliation
Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Official's Role
Principal Investigator
Facility Information:
Facility Name
Samsung Medical Center
City
Seoul
ZIP/Postal Code
06315
Country
Korea, Republic of
12. IPD Sharing Statement
Learn more about this trial
Extent of ILM Removal and Its Impact on Outcomes of MH Surgery
We'll reach out to this number within 24 hrs